Investigational Site Number : 7240004

Barcelona, Catalunya [Cataluña] 08036

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Neoplasm

Studies at this site

• A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors — Stopped early